UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 18, 2022
Form:S-3
CIK:0001404644
Company Name:Neoleukin Therapeutics, Inc.
File Number:333-264803
Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Neoleukin Therapeutics Charts.
Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Neoleukin Therapeutics Charts.